HomeHeadlinesMerck (MRK) is among those interested in Inhibrx's (INBX) experimental cancer drug, Reuters reports citing sourceAPRIL 22, 2026 AT 11:01 AMMerck (MRK) is among those interested in Inhibrx's (INBX) experimental cancer drug, Reuters reports citing sourceByNewsquawk StaffImportanceLevel 1#GERMANY#EUROPE#MERCK & CO INC#MRK.US#MERCK KGAA#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#DAX 40 INDEX#MRK#US EQUITIES
APRIL 22, 2026 AT 11:01 AMMerck (MRK) is among those interested in Inhibrx's (INBX) experimental cancer drug, Reuters reports citing sourceByNewsquawk StaffImportanceLevel 1#GERMANY#EUROPE#MERCK & CO INC#MRK.US#MERCK KGAA#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#DAX 40 INDEX#MRK#US EQUITIES
